Edition:
United Kingdom

Crinetics Pharmaceuticals Inc (CRNX.OQ)

CRNX.OQ on NASDAQ Stock Exchange Global Select Market

17.74USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$17.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,386
52-wk High
$40.78
52-wk Low
$17.32

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Wendall Wierenga

71 2015 Independent Chairman of the Board

R. Scott Struthers

57 2008 President, Chief Executive Officer, Director

Marc Wilson

40 2018 Chief Financial Officer

Stephen Betz

52 2009 Vice President - Biology

Gina Ford

2019 Vice President, Corporate Strategy and Commercial Planning